Gilead’s Irish business sees profit slump on falling sales of Covid drug
Business which accounts for close to one-third of group sales also took in €437m in dividends from subsidiaries dotted worldwide
Gilead Sciences
Gilead’s Irish unit pays out dividends of €2.8bn over two years
New accounts show that Cork-based HIV and hepatitis C drug maker had bumper year in 2021 driven by sales of Covid-19 drug Veklury
Gilead gets approval for €45m expansion of Carrigtwohill site
US pharma giant, which employs 500 people in Ireland, says development will facilitate additional future investment in the State
Putting Ireland at the forefront of medicine development for children
Interview: Gilead's Daniel O'Day on new medicines, winning the Covid battle and the search for cancer cures
US drug giant Gilead opens child medicine centre of excellence in Dublin
Docklands site will run clinical trials for paediatric versions of current and future drugs
Merck struggles to win European approval for Covid antiviral pill
Limited efficacy means it is increasingly seen as a therapy for those who cannot take rival medications
Moderna faces shareholder pressure over vaccine costs
Shareholder proposal demands pharma group open up Covid-19 vaccine tech to poorer countries
Gilead Sciences Irish pharma unit records $1.84bn loss
The loss last year followed a pre-tax profit of $288.4m in 2019
India reels from ‘black fungus’ epidemic after Covid wave eases
Mucormycosis cases soar to 30,000 from negligible levels within three weeks
Up to 70 jobs at risk at Westbourne IT in Cork city
Company seeking alternative roles for staff after loss of contract with Gilead Sciences
Covid drug drives 26% rise in fourth quarter revenue at Gilead
Company said the Covid-19 pandemic continues to affect its sales, but growth expected
Coronavirus: US records its highest daily death toll as Germany extends lockdown
World round-up: India’s daily rise in cases stays below 40,000 for fourth day
European stocks up, US futures mixed as hopes rise for economic stimulus
Stoxx Europe 600 Index headed for its third week of gains
WHO group recommends against use of remdesivir drug for Covid-19
Expert WHO panel finds ‘no evidence’ that antiviral drug improves patient outcomes
Irish banks push Iseq higher as Barclays results cheer investors
European markets still post biggest weekly drop in a month
Remdesivir has little effect on Covid-19 mortality, WHO study says
Significant blow to hopes of identifying existing medicines to treat disease
No remdesivir shortage in Ireland, HSE says as concern grows for Europe’s supply
Acute shortages reported in number of countries because of difficulties with stocks from US
Trump administered drastic combination of treatments for Covid-19
Experimental blend of drugs may suggest US president more ill than medical team admits
‘Next 48 hours critical’: Contradictory views on Trump’s Covid progress
Doctor ‘extremely happy’, but source close to president strikes a more negative note
Markets gain as Covid-19 vaccine progress lifts investors’ spirits
Iseq rises 0.48% on the day, with Ryanair and Aer Lingus owner IAG among travel gainers
Wall St sets upbeat tone for European stocks, airlines jump
Ryanair closes higher on news that British government is to ramp up Covid testing plans
Merck to move Covid-19 treatment into large trials
Drugmaker more upbeat on full-year impact after sharp drop in medical visits early in the pandemic
Gilead to add 140 jobs in Ireland as it plans new Dublin base
Company to invest €7m as it also establishes paediatric centre of excellence here
Gilead’s remdesivir endorsed as first treatment for Covid-19 in Europe
EMA committee recommends drug’s use in adults and adolescents from 12 years of age
European equity markets pause for breath following surge
Markets report: Losses in technology and healthcare stocks halt a recent rally
European shares pull back from three-month highs after rally
The pan-European Stoxx 600 declined 0.8 per cent earlier, led lower by personal and household goods
AstraZeneca and Gilead explore possibility of merger
Shares dip as it emerges there are no active talks on what would be politically sensitive deal
Global stocks climb near three-month highs as rebound hopes grow
Investors back belief economic downturn from Covid-19 pandemic has bottomed out
Merck leaps into Covid-19 development fray with vaccine, drug deals
Company buys vaccine maker Themis and announced collaboration on two vaccines
Biopharma companies make component to support 180,000 Covid tests
Group of multinationals in Ireland has worked with academics in the pharma sector
US accuses China-linked hackers of stealing coronavirus research
Chinese Embassy in Washington condemned the allegations as ‘lies’
Hi-spec south Dublin industrial facility seeks €2.5m
Stillorgan Industrial Estate unit equipped for pharma R&D and medical manufacturing
Roche receives emergency-use authorisation for Covid-19 antibody test
The Swiss pharma company received the clearance from the US Food and Drug Administration
Ebola drug remdesivir leads race for effective Covid-19 treatment
Trial shows drug ‘has a clear-cut, significant, positive effect in diminishing the time to recovery’
Oil prices rise as cuts calm storage fears
Norway to cut production by 10% as demand shrinks by a third
Trump says China ‘will do anything they can’ to make him lose re-election bid
US president looking at different options in terms of consequences for Beijing over virus
European stocks rise as banks and oil stocks lead gains
Renewed hopes for Covid-19 treatment boosts investor sentiment
Irish patients to be involved in trials for Covid-19 drug treatments
Anti-virals designated for investigation by WHO to be tested on wider international scale
Gilead antiviral drug remdesivir flops in first trial
Disappointing results revealed in draft documents published accidentally by WHO
Stocks rally on hopes for Covid-19 treatment
Iseq outperforms European peers and rises 3.83%, with Flutter a standout performer
Investors could pay high price as equities continue to rally
Central banks’ stimulus has driven relentless rebound but it comes at a cost that markets haven’t priced in
Gilead’s coronavirus drug: why experts are cautious on its prospects
US shares rise after leaked report enthused about benefits of remdesivir in 125 Covid-19 patients
Gilead drug boosts investor hopes for coronavirus treatment
Early impressions from US study show severely ill patients in clinical trial recovering quickly
Coronavirus: Vaccines need scientific scrutiny despite global rush, warns expert
Already many ‘stupid studies being published’ without peer review, says Luke O’Neill
Prospect of interest rate cuts helps global markets recover
Markets report: Iseq was virtually flat on the day with Ryanair amongst losers
Ryanair drives Iseq gains as European markets rebound
Sterling weakens as investors grow nervous over smooth trade deal post-Brexit
Gilead accused of breaching Irish patent for HIV drug
ViiV Healthcare Company and Shionogi & Co are suing Gilead and its Irish subsidiary
Profits soar at Irish arm of Gilead even as revenues decline
Cork-based division of pharma giant reports pretax profits of €130m
US sues Gilead over HIV patent infringements
Lawsuit claims drugmaker reaped billions of dollars through taxpayer-funded research
Sale of psoriasis drug Otezla will clear way for €74m Celgene deal
Bristol-Myers Squibb’s acquisition of Celgene goes ahead after Amgen pays €13.4bn for drug
London’s week-long losing streak ends on strong Chinese growth
China figures lift European markets and ease investor concerns over global slowdown
European shares retreat over Italian budget concerns
Irish shares outperform peers with benchmark index rising 0.62%
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices